title: Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.
abstract: Disruption of the sarcolemmal membrane is a defining feature of oncotic death in cardiac ischaemia-reperfusion (I-R), and its molecular makeup not only fundamentally governs this process but also affects multiple determinants of both myocardial I-R injury and responsiveness to cardioprotective stimuli. Beyond the influences of membrane lipids on the cytoprotective (and death) receptors intimately embedded within this bilayer, myocardial ionic homeostasis, substrate metabolism, intercellular communication and electrical conduction are all sensitive to sarcolemmal makeup, and critical to outcomes from I-R. As will be outlined in this review, these crucial sarcolemmal dependencies may underlie not only the negative effects of age and common co-morbidities on myocardial ischaemic tolerance but also the on-going challenge of implementing efficacious cardioprotection in patients suffering accidental or surgically induced I-R. We review evidence for the involvement of sarcolemmal makeup changes in the impairment of stress-resistance and cardioprotection observed with ageing and highly prevalent co-morbid conditions including diabetes and hypercholesterolaemia. A greater understanding of membrane changes with age/disease, and the inter-dependences of ischaemic tolerance and cardioprotection on sarcolemmal makeup, can facilitate the development of strategies to preserve membrane integrity and cell viability, and advance the challenging goal of implementing efficacious 'cardioprotection' in clinically relevant patient cohorts. Linked Articles This article is part of a themed section on Molecular Pharmacology of G Protein-Coupled Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.20/issuetoc.
authors.affiliation: Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.|Critical Care Research Group, The Prince Charles Hospital and The University of Queensland, Chermside, Queensland, Australia.
authors.forename: Louise E
authors.initials: LE
authors.lastname: See Hoe
authors.affiliation: Monash Institute of Pharmaceutical Sciences, Monash University, Clayton, VIC, Australia.
authors.forename: Lauren T
authors.initials: LT
authors.lastname: May
authors.affiliation: Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
authors.forename: John P
authors.initials: JP
authors.lastname: Headrick
authors.affiliation: Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia. j.peart@griffith.edu.au.
authors.forename: Jason N
authors.initials: JN
authors.lastname: Peart
mesh_terms: D000367:Age Factors; D000818:Animals; D002318:Cardiovascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D006801:Humans; D017202:Myocardial Ischemia / Q000378:metabolism / Q000517:prevention & control*; D018384:Oxidative Stress; D012508:Sarcolemma / Q000378:metabolism*